Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

DBV Launches Peanut Patch Study in Infants as Young as Six Months

Researchers Report Lasting Allergy Benefits From Specific Infant Formula

Moonlight Therapeutics Launches First Clinical Trial of Microneedle Peanut Allergy Therapy

New Biologic Aims to Provide Long-Lasting Protection for People With Food Allergies

Researchers Develop Novel Treatment by Unfolding Peanut Proteins

FDA Delays Approval of Aquestive’s Anaphylm™ Sublingual Epinephrine Film

Nasus Pharma’s Nasal Epinephrine Powder Shows Faster Relief Than EpiPen

GSK’s $2.2 Billion Acquisition of Rapt Signals a New Era for...

Beyond Desensitization: How PRT120 Rewires the Immune System for Peanut Allergy...

Aquestive Works with FDA to Resolve Hurdles for its New Sublingual...

Hope on the Horizon: Ten Food Allergy Research Breakthroughs in 2025

Very Low-Dose Multi-Nut OIT Promising for Children with Multiple Food Allergies

DBV to Submit FDA Application After Viaskin Peanut Patch Achieves Goals...

Mabylon Begins Human Clinical Trials of New Peanut Allergy Treatment

Phase II Trial Now Recruiting, Investigates Microbiome as Immunotherapy Enhancer

Follow Us

Your School On Our Map

Put Your School on the Map